Marshall Wace
CCX.WS

Marshall Wace’s Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe CCX.WS Stock Holding History

Marshall Wace’s Portfolio CCX.WS Stock Details CCX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-233,332
Closed -$345K – 2368
2020
Q3 		$509K Hold
233,332
– – ﹤0.01% 1240
2020
Q2 		$674K Hold
233,332
– – ﹤0.01% 1109
2020
Q1 		$385K Hold
233,332
– – ﹤0.01% 1037
2019
Q4 		$331K Buy
+233,332
New +$350K ﹤0.01% 1251

Other funds holding CCX.WS

BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

Marshall Wace's CCX.WS Position: Q4 2020 in Review

Marshall Wace sold out of Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe (CCX.WS) in Q4 2020, closing a stake of 233,332 shares — an estimated $345K sold.

Marshall Wace first reported a position in CCX.WS in Q4 2019 and held it in 4 quarters. The position peaked at $674K in Q2 2020. 31 funds tracked by Wall St. Rank hold CCX.WS as of Q4 2020.

  • Marshall Wace reported no remaining Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace sold 233,332 Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe shares in Q4 2020, an estimated $345K.
  • Marshall Wace first reported a position in Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe in Q4 2019 and held it in 4 quarters.
  • Marshall Wace's Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe position peaked at $674K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe as of Q4 2020.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.